| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer | Chief Scientific Officer
1 company
Edward P. Feener last filed a Form 4 in May 2024, as Chief Scientific Officer at KALV. From September 2018 to May 2024, the filings on record show 0 open-market purchases and 23 sales. Edward P. Feener's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Historically, Edward P. Feener's trades have earned a strong insider score of 72/100 across 17 rated trades. Over a 12-month horizon, 64.7% of those trades were profitable, with an average 12-month return of +18.0%.
At the last filing, the largest reported position was 72,858 shares of KALV. The KALV filings lean toward selling, a net 237,857 shares.
Shares as reported in the last Form 4 for each company; the most recent is from May 2024. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 23, 2019 | KALV Kalvista Pharmaceuticals, Inc. | Chief Scientific Officer | Sell | 3,300 | $18.62 | $61,443.01 | -3.3% | |
| Apr 17, 2019 | KALV Kalvista Pharmaceuticals, Inc. | Chief Scientific Officer | Sell | 4,000 | $24.92 | $99,666.27 | -3.8% | |
| Jan 16, 2019 | KALV Kalvista Pharmaceuticals, Inc. | Chief Scientific Officer | Sell | 4,000 | $19.55 | $78,209.88 | -3.7% |